Logo

PierianDx

People in the News: New Appointments at Precipio, ERS Genomics, Omniome, PierianDx, More

Belgian Society of Medical Oncology to Study Value of Genomic Profiling for Cancer Patients

The Belgian Society of Medical Oncology has partnered with Illumina, OncoDNA, and PierianDx for this study, which will enroll 864 patients with advanced metastatic cancer.

Illumina, PierianDx Expand Partnership on Cancer Panel Test Reporting

The deal builds on a non-exclusive partnership signed in January 2019 and PierianDx will now support three more Illumina cancer sequencing assays.

PierianDx, Pillar Biosciences Partner to Streamline NGS Cancer Analysis

PierianDx will integrate its cancer profiling assays with Pillar Biosciences' PiVAT bioinformatics pipeline on a GPDR-compliant platform.

PierianDx, University Hospital of Augsburg Tailoring NGS Workflow to European Market

The German hospital will build interpretation and reporting on the PierianDx Clinical Genomics Workspace for two Illumina assays.

Oct 28, 2019

PierianDx Raises $27M in Series B Round

Jul 1, 2019

MMRF to Bolster Recently Launched Clinical, Genomic Patient Data Registry With Immune Profiles
Premium

Mar 12, 2019

Forensic Genomics Firm Othram Raises $4M

Feb 14, 2019

Q&A: Andreessen Horowitz's Jorge Conde Discusses Power of Meshing Biology and Engineering
Premium

Jan 4, 2019

Illumina, PierianDx to Collaborate on Cancer Sequencing Assays

Jun 1, 2018

2bPrecise, PierianDx to Develop Point-of-Care Technology for Precision Medicine

May 15, 2018

PierianDx Partners With ScienceVision to Bring Clinical Genomics Platform to Asia

Apr 17, 2018

RTI, PierianDx Collaborate on Clinical Genomics Platform

Mar 14, 2018

PierianDx, Cancer Genetics Partner on Precision Cancer Medicine Offering

Feb 13, 2018

PierianDx Raises $3M in New Funding, Seeks $2M More

Mar 10, 2017

PierianDx Customers Cite 'Creative Partnership' on Clinical Genomics as Key Selling Point
Premium

Nov 2, 2015

Acquisition of Knome Assets Expands Tute Interpretation Toolkit
Premium

Nov 2, 2015

Tute Genomics Acquires Knome

Jan 12, 2015

Genalice, Knome to Jointly Offer NGS Analysis Solutions

Oct 1, 2014

Swiss Foundation Taps Genalice, Knome for Rare Disease Research

Sep 23, 2014

Knome Joins the Global Alliance for Genomics and Health

Sep 9, 2014

Knome Providing NGS Data Interpretation Solution to LabCentral Startups for Free

Aug 15, 2014

Downloads and Upgrades: IMPROVER COPD Models and KnoSys 3.0
Premium

Apr 18, 2014

People in the News: Josh Forsythe and Mark Pottle
Premium

Apr 11, 2014

Belgian Firm Gentle Adds New Human Genome Interpretation Service to Product Portfolio
Premium

Breaking News
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.